|
RAB14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.52450007751793E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5543999965526E-09 |
| Normal-vs-Stage2 |
1.660420E-02 |
| Normal-vs-Stage3 |
4.55010000000033E-06 |
| Normal-vs-Stage4 |
3.811700E-02 |
| Stage1-vs-Stage2 |
3.099200E-01 |
| Stage1-vs-Stage3 |
4.431600E-01 |
| Stage1-vs-Stage4 |
9.945000E-01 |
| Stage2-vs-Stage3 |
1.038450E-01 |
| Stage2-vs-Stage4 |
4.675200E-01 |
| Stage3-vs-Stage4 |
6.272400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.29319999153665E-09 |
| Normal-vs-AfricanAmerican |
6.42690000000057E-05 |
| Normal-vs-Asian |
3.165900E-02 |
| Caucasian-vs-AfricanAmerican |
4.761800E-01 |
| Caucasian-vs-Asian |
3.694200E-01 |
| AfricanAmerican-vs-Asian |
2.283600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.87050416559032E-11 |
| Normal-vs-Female |
2.798800E-03 |
| Male-vs-Female |
7.176300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.84390000046442E-07 |
| Normal-vs-Extreme_Weight |
3.09459999847661E-08 |
| Normal-vs-Obese |
1.402320E-03 |
| Normal-vs-Extreme_Obese |
4.015800E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.705200E-01 |
| Normal_Weight-vs-Obese |
1.159620E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.350800E-01 |
| Extreme_Weight-vs-Obese |
1.675800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.299000E-01 |
| Obese-vs-Extreme_Obese |
7.161600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.501900E-03 |
| Normal-vs-Age(41-60Yrs) |
1.984120E-04 |
| Normal-vs-Age(61-80Yrs) |
4.39960290421482E-11 |
| Normal-vs-Age(81-100Yrs) |
3.796700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.843000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.362800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.210800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.079710E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.536820E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.486000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.59640000008521E-07 |
| Normal-VS-Type2 PRCC |
3.1629998620275E-10 |
| Normal-VS-KIRP CIMP |
4.698100E-02 |
| Normal-VS-Unclassified PRCC |
1.482760E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.546000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.846400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.342600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.756000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.258000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.446800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89469995248714E-10 |
| Normal-vs-N1 |
8.645900E-04 |
| Normal-vs-N2 |
6.676800E-03 |
| N0-vs-N1 |
3.433000E-01 |
| N0-vs-N2 |
5.628800E-01 |
| N1-vs-N2 |
9.452400E-01 |
|
|
